American Century Companies’s Global Cord Blood Corporation CO Stock Holding History

American Century Companies’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20,591	Closed	-$61.5K	–	2882
2023 Q1	$61.5K	Hold	20,591	–	–	﹤0.01%	2604
2022 Q4	$61.5K	Hold	20,591	–	–	﹤0.01%	2517
2022 Q3	$62K	Hold	20,591	–	–	﹤0.01%	2390
2022 Q2	$61K	Hold	20,591	–	–	﹤0.01%	2271
2022 Q1	$79K	Hold	20,591	–	–	﹤0.01%	2256
2021 Q4	$86K	Hold	20,591	–	–	﹤0.01%	2271
2021 Q3	$96K	Buy	20,591 +4,269	+26%	+$20.9K	﹤0.01%	2239
2021 Q2	$87K	Buy	16,322 +990	+6%	+$5.18K	﹤0.01%	2248
2021 Q1	$69K	Buy	+15,332	New	+$66.5K	﹤0.01%	2173

Other funds holding CO

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return

Operose Advisors Milwaukee, Wisconsin $431M AUM 20.45% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

American Century Companies's CO Position: Q2 2023 in Review

American Century Companies sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 20,591 shares — an estimated $61.5K sold.

American Century Companies first reported a position in CO in Q1 2021 and held it in 9 quarters. The position peaked at $96K in Q3 2021. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

American Century Companies reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
American Century Companies sold 20,591 Global Cord Blood Corporation shares in Q2 2023, an estimated $61.5K.
American Century Companies first reported a position in Global Cord Blood Corporation in Q1 2021 and held it in 9 quarters.
American Century Companies's Global Cord Blood Corporation position peaked at $96K in Q3 2021.
6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on American Century Companies's 13F filing for Q2 2023, filed 14 Aug 2023.